Private Capital Group’s ANI Pharmaceuticals ANIP Stock Holding History

Private Capital Group’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-766	Closed	-$47K	–	1969
2019 Q4	$47K	Buy	766 +92	+14%	+$6.09K	0.01%	769
2019 Q3	$49K	Sell	674 -149	-18%	-$11.1K	0.01%	786
2019 Q2	$55K	Buy	823 +87	+12%	+$6.19K	0.01%	619
2019 Q1	$52K	Hold	736	–	–	0.01%	750
2018 Q4	$33K	Sell	736 -87	-11%	-$4.56K	0.01%	855
2018 Q3	$46K	Hold	823	–	–	0.01%	752
2018 Q2	$54K	Hold	823	–	–	0.01%	658
2018 Q1	$48K	Buy	823 +194	+31%	+$12.3K	0.01%	696
2017 Q4	$56K	Buy	+629	New	+$39.1K	0.01%	646

Other funds holding ANIP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ICOM

Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Private Capital Group's ANIP Position: Q1 2020 in Review

Private Capital Group sold out of ANI Pharmaceuticals (ANIP) in Q1 2020, closing a stake of 766 shares — an estimated $47K sold.

Private Capital Group first reported a position in ANIP in Q4 2017 and held it in 9 quarters. The position peaked at $56K in Q4 2017. 140 funds tracked by Wall St. Rank hold ANIP as of Q1 2020.

Private Capital Group reported no remaining ANI Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
Private Capital Group sold 766 ANI Pharmaceuticals shares in Q1 2020, an estimated $47K.
Private Capital Group first reported a position in ANI Pharmaceuticals in Q4 2017 and held it in 9 quarters.
Private Capital Group's ANI Pharmaceuticals position peaked at $56K in Q4 2017.
140 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2020.

Based on Private Capital Group's 13F filing for Q1 2020, filed 7 May 2020.